Effectiveness of high-intensity laser therapy on post-needling soreness in the trigger point of the upper trapezius muscle: A randomized double-blinded sham-controlled trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 41914595.
- Also identified by DOI 10.1177/10538127261432695.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
BackgroundDry needling (DN) has been recognized as an effective intervention for the inactivation of myofascial trigger points. Nevertheless, post-needling soreness is the most frequently reported adverse event associated with this procedure.ObjectivesThis study aimed to evaluate the effectiveness of high-intensity laser therapy (HILT) in reducing post-needling soreness in an active MTrP of the upper trapezius muscle compared to a sham laser.MethodsPatients were randomly allocated to receive either HILT (n = 32) or sham (n = 32). The HILT of wavelength 1064 nm with total energy 900 J, divided into three phases, was applied for seven minutes. The participants rated post-needling soreness using a 100-mm visual analog scale (VAS) before performing and immediately after completing laser therapy. A 7-day pain diary, recording daily soreness and pain relief measures, was instructed.ResultsThere was no statistically significant difference in post-intervention VAS and change in VAS between the two groups. The mean duration required for pain resolution and the use of pain relief medications over 7 days following the intervention did not differ statistically between groups.ConclusionsHILT did not show a significant immediate effect in relieving post-needling soreness, nor in reducing the time to its resolution.